Two-year multicomprehensive secondary prevention program: Favorable effects on cardiovascular functional capacity and coronary risk profile after acute myocardial infarction

Journal of Cardiovascular Medicine

Volumn 10, Issue 10, 2009, Pages 772-780

  Giallauria, Francesco ^a,b   Lucci, Rosa ^a   D'Agostino, Mariantonietta ^a   Vitelli, Alessandra ^a   Maresca, Luigi ^a   Mancini, Maria ^a   Aurino, Mario ^a   Del Forno, Domenico ^a   Giannuzzi, Pantaleo ^c   Vigorito, Carlo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c IRCCS   (Italy)

Author keywords

Cardiac rehabilitation; cardiopulmonary exercise testing; exercise training; lipid profile; long term multi comprehensive cardiac rehabilitation; multi comprehensive approach; myocardial infarction; oxygen consumption; secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BEHAVIOR THERAPY; BODY MASS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORONARY RISK; EXERCISE; FEMALE; FUNCTIONAL STATUS; HEALTH EDUCATION; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TRAINING; WORKLOAD;

EXERCISE TEST; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXYGEN CONSUMPTION; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 70349119481     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832d55fe     Document Type: Article

References (44)

1. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. New Engl J Med 2001; 345:892-902.
2. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003; 10:S1-S10.
3. Giannuzzi P, Mezzani A, Saner H, Björnstad H, Fioretti P, Mendes M, et al. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil 2003; 10:319-327.
4. Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol 2008; 51:1619-1631.
5. Brubaker PH, Warner JG, Rejeski WJ, Edwards DG, Matrazzo BA, Ribisl PM, et al. Comparison of standard-length and extended-length participation in cardiac rehabilitation on body composition, functional capacity, and blood lipids. Am J Cardiol 1996; 78:769-773.
6. Dafoe W, Arthur H, Stokes H, Morrin L, Beaton L, Canadian Cardiovascular Society Access to Care Working Group on Cardiac Rehabilitation. Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitation. Can J Cardiol 2006; 22:905-911.
7. Griffo R, Urbinati S, Giannuzzi P, Jesi AP, Sommaruga M, Sagliocca L, et al. Italian guidelines on cardiac rehabilitation and secondary prevention of cardiovascular disease: executive summary. G Ital Cardiol (Rome) 2008; 9:286-297.
8. Taylor RS, Brown A, Ebrahim S, Joliffe J, Noorani H, Rees K, et al. Exercisebased rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized trials. Am J Med 2004; 116:682-697.
9. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005; 143:659-672.
10. Giallauria F, De Lorenzo A, Pilerci F, Manakos A, Lucci R, Psaroudaki M, et al. Reduction of NT-pro-BNP levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur J Cardiovasc Prev Rehabil 2006; 13:625-632.
11. Giallauria F, Lucci R, Pietrosante M, Gargiulo G, De Lorenzo A, D'Agostino M, et al. Exercise-based cardiac rehabilitation improves heart rate recovery in elderly patients after acute myocardial infarction. J Gerontol A Biol Sci Med Sci 2006; 61:713-717. (Pubitemid 44148358)
12. Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, et al. Left ventricular remodeling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-Brain Natriuretic Peptide. Eur J Cardiovasc Prev Rehabil 2008; 15:113-118.
13. Giallauria F, Galizia G, Lucci R, D'Agostino M, Vitelli A, Maresca L, et al. Favourable effects of exercise-based cardiac rehabilitation after acute myocardial infarction on left atrial remodelling. Int J Cardiol (in press). doi: 10.1016/j.ijcard.2008.05.026
14. Oldridge N. Compliance with cardiac rehabilitation services. J Cardiopulm Rehabil 1991; 11:115-127.
15. Moore SM, Charvat JM, Gordon NH, Pashkov F, Ribisl P, Roberts BL, et al. Effects of a CHANGE intervention to increase exercise maintenance following cardiac events. Ann Behav Med 2006; 31:53-62.
16. Willich SN, Muller-Nordhorn J, Kulig M, Binting S, Gohlke H, Hahmann H, et al. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. Eur Heart J 2001; 22:307-313.
17. Dorn J, Naughton J, Imamura D, Trevisan M, for the NEHDP Project Staff. Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction patients. Circulation 1999; 100:1764-1769.
18. EUROASPIRE Study Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.
19. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006; 47:2130-2139. (Pubitemid 44275145)
20. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89:975-990.
21. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280:2001-2007.
22. Lear SA, Spinelli JJ, Linden W, Brozic A, Kiess M. The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. Am Heart J 2006; 152:333-339.
23. Frohlich JJ, Ignaszewski A, The Vestfold Heartcare Study Group. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention program in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 2003; 10:429-437.
24. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines [Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction]. J Am Coll Cardiol 2004; 44:E1-E211.
25. Weber CT, Janicki JS, McElroy PA. Cardiopulmonary Exercise Testing (CPX). In: Weber CT, Janicki JS, editors. Cardiopulmonary exercise testing. Philadelphia, PA: WB Saunders; 1986. pp. 151-167.
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
27. Giallauria F, De Lorenzo A, Pilerci F, Manakos A, Lucci R, Psaroudaki M, et al. Long-term effects of cardiac rehabilitation on end-exercise heart rate recovery after myocardial infarction. Eur J Cardiovasc Prev Rehabil 2006; 13:544-550. (Pubitemid 44162155)
28. Sans S, Kesteloot H, Kromhout D, On behalf of the Task Force. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18:1231-1248.
29. De Velasco JA, Rodriguez JA, Ridocci F, Aznar J. Action to improve secondary prevention in coronary artery disease patients: one-year followup of a shared care program. Eur Heart J Suppl 2004; 6 (Suppl J):J27-J32.
30. Arrigo I, Brunner-LaRocca H, Lefkovits M, Pfisterer M, Hoffmann A. Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence. Eur J Cardiovasc Prev Rehabil 2008; 15:306-311.
31. Zwisler AD, Soja AM, Rasmussen S, Frederiksen M, Abadini S, Appel J, et al. Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial. Am Heart J 2008; 155:1106-1113.
32. Aadahl M, Kjaer M, Kristensen JH, Mollerup B, Jørgensen T. Self-reported physical activity compared with maximal oxygen uptake in adults. Eur J Cardiovasc Prev Rehabil 2007; 14:422-428.
33. Ades PA, Savage PD, Poehlman ET, Brochu M, Fragnoli-Munn K, Carhart RL Jr. Lipid lowering in the cardiac rehabilitation setting. J Cardiopulm Rehabil 1999; 19:255-260.
34. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001; 33:S502-S515.
35. Kokkinos PF, Fernhall B. Physical activity and high-density lipoprotein cholesterol levels. What is the relationship? Sports Med 1999; 28:307-314.
36. Linke A, Erbs S, Hambrecht R. Effects of exercise training upon endothelial function in patients with cardiovascular disease. Front Biosci 2008; 13:424-432.
37. Franklin BA, Trivax JE, Vanhecke TE. New insights in preventive cardiology and cardiac rehabilitation. Curr Opin Cardiol 2008; 23:477-486.
38. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al. Prediction of long-term prognosis in 12, 169 men referred for cardiac rehabilitation. Circulation 2002; 106:666-671.
39. Corrà U, Mezzani A, Bosimini E, Giannuzzi P. Prognostic value of timerelated changes of cardiopulmonary exercise testing indices in stable chronic heart failure: a pragmatic and operative scheme. Eur J Cardiovasc Prev Rehabil 2006; 13:186-192.
40. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler HA. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990; 322:1700-1707.
41. Sierra-Johnson J, Wright SR, Lopez-Jimenez F, Allison TG. Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol 2005; 96:211-214.
42. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Thomas RJ, Squires RW, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 2008; 15:336-340.
43. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008; 155:772-779.
44. Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, et al. Global Secondary Prevention Strategies to limit event recurrence after myocardial infarction. Arch Intern Med 2008; 168:2194-2204.